DOCSLIB.ORG

Why Millennials Are Consuming the Best Stimulants at an Accelerating Rate

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Why Millennials Are Consuming the Best Stimulants at an Accelerating Rate Why Millennials are Consuming the Best Stimulants at an Accelerating Rate Author : Bruno Souza The sudden spike of internet searches on the best places online to buy modafinil are mainly attributed to millennials. This data seems out of place right next to another statistic that says that millennials are sleeping more hours, compared to other generations. Since Modafinil is one of the best wakefulness promoting agents or stimulants currently available, these two statistics seem inconsistent. Before dismissing one or both of these findings, a closer look at the stats and other variables involved do support these findings. So why are millennials consuming the best stimulants at an accelerating rate? Are Millennials Really Sleeping Better? 1 / 8 A study by the United States Bureau of Labor and statistics show that millennials, or those who were born between 1981 and 1996 (approximately), sleep some 25 minutes longer each night. With an average duration of sleep each night for Americans at 6.8 hours, millennials are within the recommended seven to eight hours of sleep. Another positive data for millennials that came out of this study is that, despite the longer sleep hours, those who are employed are putting in more hours at work. This side data may support the data about stimulants, but more on that later. What may appear as improved sleep quality for millennials does have its naysayers. Some attribute the longer hours of sleep to unemployment as unemployment and underemployment rate among millennials are twice the national average. According to naysayers, this supposed better sleep quality may not be better at all because unemployment is causing an artificial spike in the data. There is, however, a more viable explanation for the improved sleep quality in millennials and it has something to do with the positive behavior that this generation is known for. Perhaps learning from the bad habits of the previous generation, millennials have placed emphasis on the importance of balancing work with life beyond the cubicles and workstations. Millennials are collectively more conscious of their personal development and to achieve growth, this generation is keen on working under more flexible conditions to give themselves time for resting and relaxing. This point brings to focus the other, largely unnoticed variable in this discussion, which are stimulants. Adderall & Amphetamines 2 / 8 Stimulants are wakefulness-promoting agents that are primarily prescribed for those who are suffering from sleep disorders such as narcolepsy, which is a condition typified by bouts of extreme daytime sleepiness. One of the most popular stimulants among young professionals and students is Adderall. Along with Modafinil, Adderall is also one of the most searched wakefulness promoting agents online. Other examples of stimulants include caffeine, amphetamines, methamphetamines and cocaine. As you can see from these examples, the more popular types of stimulants do not have a good reputation. Amphetamines, in controlled and therapeutic doses, can help manage cases of attention deficit hyperactivity disorder (ADHD), promote wakefulness, increase muscle strength and improve some cognitive functions. Even in slightly larger doses though, amphetamines have the opposite effect, causing impairment in cognitive function and the loss of lean muscle mass. Higher doses, such in cases of those who use amphetamines for recreational purposes, can result in psychosis and paranoia. These effects are similar to the well-documented negative effects of methamphetamine and cocaine abuse. 3 / 8 Much like amphetamines, Adderall is a drug that is usually prescribed for those suffering from ADHD and narcolepsy. As a psychostimulant that belongs to the family of phenethylamines, it shares chemical similarities with amphetamines. This is the reason why it has almost the same positive and negative effects. Despite these dangers, users of this drug for recreational or nootropic use are under the mistaken impression that it is safer than amphetamines. However, not only does Adderall share the same ill-effects with amphetamines, it can likewise cause insomnia, loss of appetite and dry mouth even in therapeutic doses. Caffeine, which can be consumed from regular breakfast coffee, is easily the most benign type of stimulant in this section. It has long been consumed to stave off sleepiness and improve focus and alertness. Those who take it as a cognitive enhancing agent, usually stack it with l-theanine as a starter nootropic stack. When taken in larger doses such as in appetite suppressants, caffeine can cause cognitive impairment and other side- effects including nausea, headaches and poor sleep quality. If Adderall and amphetamines are not the best choices for stimulants and cognitive enhancement, are there better alternatives? The simple answer yes. Best Stimulants 4 / 8 There are better alternatives both for promoting wakefulness and as a nootropic agent. This discussion will look closely at three stimulants: Modafinil, Adrafinil and Fluorenol. Modafinil As a testament to the effectiveness of Modafinil as a stimulant, the U.S. military has it as a standard supplement for the U.S. Air Force pilots for long sorties, as well as for other military personnel engaged in active combat duty. More than just to keep pilots and soldiers awake, Modafinil is the military’s “go pill” to help ward off fatigue. Modafinil was developed by Laboratoires Lafon, which is the same pharmaceutical company that developed Adrafinil. In fact, Modafinil was developed from Adrafinil. Although both became available in the mid-1970s, the U.S. Food and Drug Administration only approved the medical use of Modafinil more than 20 years later in 1998. Along with Adrafinil, Modafinil belongs to a drug family called “eugeroics.” This family of drugs is a popular treatment and management option for a wide variety of neurological conditions such as Parkinson’s disease, neurological fatigue brought on by multiple sclerosis, cognitive impairment due of cancer treatments, drug addiction and chronic depression. What sets Modafinil apart from Adderall and amphetamines is that it does not give you an edgy type of wakefulness that is common with amphetamines, which gives you better focus and concentration. This is a plus for those who are looking to add Modafinil to their nootropic stacks. Even after its effects wear off, Modafinil does not cause anxiety, headaches and paranoia, unlike amphetamines. Because of its ability to also increase physical performance, Modafinil is included in the World Anti-Doping Agency’s list of banned performance enhancers. As a nootropic, Modafinil does show some cognitive enhancing capabilities, either on its own or as part of a stack. Its use is popular among young professionals and students as a work and study aid. With the ability to increase alertness, improve focus and enhance mental energy, Modafinil is a good addition to nootropic stacks with racetams and ampakines. Modafinil also shows promise in helping rehabilitate the cognitive abilities of recovering methamphetamine and cocaine addicts. Adrafinil Development of Adrafinil led to the creation of Modafinil. Adrafinil is a prodrug of Modafinil. This means that if you self-administer Adrafinil, the liver converts it to Modafinil in your system. These two eugeroic drugs have mirror effects, with the only difference being Modafinil having a faster-acting effect at lower doses. Modafinil is also more potent with a minimum effective dose of 100 milligrams compared to 600 milligrams for Adrafinil. Modafinil is easier on the liver and kidneys because of its high bioavailability. Fluorenol 5 / 8 Fluorenol is also considered as a eugeroic because of its wakefulness-enhancing properties. It is an alcohol derivative of fluorene and is still under research by the same company that developed both Adrafinil and Modafinil. Little is known about this eugeroic apart from the reviews of those who have used it. Initial studies show that fluorenol is even more potent than Modafinil by about 40 percent. Despite being a stronger eugeroic, it has a weaker dopamine reuptake inhibiting property. This means that it has less abuse potential than Modafinil. Buying Stimulants Online 6 / 8 Purchasing stimulants online bypasses many issues that are present when purchasing from a brick-and-mortar pharmacy. For one, Modafinil is a Schedule IV Drug in the U.S., which means that you cannot walk into Walgreens and buy it without a prescription. Adrafinil and fluorenol, on the other hand, are supposedly “discontinued” and “never distributed,” respectively. However, anyone can purchase all three stimulants online with ease. Further proof of the availability of these stimulants from online sellers can be seen in blogs and forums that are dedicated to their proper use and dosing. One big caveat for those who are thinking of buying their stimulants online is that there is a huge number of websites that sell low-quality nootropics. Worse, some may even scam unwitting buyers. To ensure that you’ll only purchase high-quality stimulants and nootropics, stick to established online nootropic dealers or those sellers that are endorsed in reputable nootropic blogs and forums. Why Millennials Are Turning to Stimulants There isn’t one definitive reason why more millennials are opting to use stimulants. Using their sleep and 7 / 8 work habits as clues, however, we can think of possible explanations for this pattern. Since it is established that millennials are getting more sleep and putting in more work hours, it is plausible that the use of stimulants is for other purposes other than staying awake. Stimulants improve focus and concentration, as well as help in sustaining a high level of mental energy for longer periods. The equation can be as simple as millennials sleep more, which in turn enables them to have better work output. The stimulants help them improve the quality of their work in the same way that it helps students with their studies. Furthermore, work conditions are also becoming more demanding and competitive, which can cause needless stress and distractions.
Load more

Recommended publications
  • Modafinil and Modafinil Analogues: Free Radical Mechanism of the Eugeroic and Cognitive Enhancment Effect Clifford Fong
    Modafinil and modafinil analogues: free radical mechanism of the eugeroic and cognitive enhancment effect Clifford Fong To cite this version: Clifford Fong. Modafinil and modafinil analogues: free radical mechanism of the eugeroic and cognitive enhancment effect. [Research Report] Eigenenergy. 2018. hal-01933737 HAL Id: hal-01933737 https://hal.archives-ouvertes.fr/hal-01933737 Submitted on 24 Nov 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Modafinil and modafinil analogues: free radical mechanism of the eugeroic and cognitive enhancment effect Clifford W. Fong Eigenenergy, Adelaide, South Australia. Keywords: Modafinil, modafinil-like analogues, eugeroic effect, cognitive enhancement, free radicals, quantum mechanics Abbreviations Dopamine DA, dopamine transporter DAT, Dissociative electron transfer or attachment DET, Linear free energy relationship LFER, free energy of water desolvation ΔG desolv,CDS , lipophilicity free energy ΔG lipo,CDS, cavity dispersion solvent structure of the first solvation shell CDS, highest occupied molecular orbital HOMO, lowest unoccupied molecular orbital LUMO, multiple correlation coefficient R 2, the F test of significance, standards errors for the estimate (SEE) and standard errors of the variables SE(ΔG desolCDS ), SE(ΔG lipoCDS ), SE(Dipole Moment), SE (Molecular Volume), transition state TS, reactive oxygen species ROS.
    [Show full text]
  • Patterns Of, and Motivations for Illicit Drug Use Among Long Haul
    Fatigue and beyond: Patterns of, and motivations for illicit drug use among long haul truck drivers Naomi Richards BPsych (Hons) This thesis is submitted for the degree of Masters of Applied Science (Research) within the Centre for Accident Research and Road Safety-Queensland (CARRS-Q), School of Psychology and Counselling, Queensland University of Technology 2004 Key words Drug use Drug use career Illicit drug use Road safety Truck drivers Abstract Long distance truck drivers are considered a special interest group in terms of drug driving research and policy due to high rates of use, involvement of drugs in truck accidents and the link between drug use and work related fatigue. Qualitative interview data was collected from 35 long haul truck drivers in South East Queensland and analysed using NVivo 2.0. High rates of licit and illicit drug use (particularly amphetamines) were reported. However, unlike previous studies which focus on fatigue, this research found overlapping and changing motivations for drug use during individual lifetimes. Using Becker’s model of a drug use ‘career’ it was revealed that some drivers begin illicit drug use before they begin truck driving. As well as fatigue, powerful motives such as peer pressure, wanting to fit the trucking ‘image’, socialisation, relaxation and addiction were reported. These may need to be considered along side fatigue in the development of effective drug prevention or cessation policies for truck drivers. Contents Page 1. Introduction 1 2. Literature Review 5 2.1. Drugs of concern to road safety 5 2.1.1. Cannabis 6 2.1.1.1. Effects of cannabis on driving performance 7 2.1.2.
    [Show full text]
  • World of Cognitive Enhancers
    ORIGINAL RESEARCH published: 11 September 2020 doi: 10.3389/fpsyt.2020.546796 The Psychonauts’ World of Cognitive Enhancers Flavia Napoletano 1,2, Fabrizio Schifano 2*, John Martin Corkery 2, Amira Guirguis 2,3, Davide Arillotta 2,4, Caroline Zangani 2,5 and Alessandro Vento 6,7,8 1 Department of Mental Health, Homerton University Hospital, East London Foundation Trust, London, United Kingdom, 2 Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 3 Swansea University Medical School, Institute of Life Sciences 2, Swansea University, Swansea, United Kingdom, 4 Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy, 5 Department of Health Sciences, University of Milan, Milan, Italy, 6 Department of Mental Health, Addictions’ Observatory (ODDPSS), Rome, Italy, 7 Department of Mental Health, Guglielmo Marconi” University, Rome, Italy, 8 Department of Mental Health, ASL Roma 2, Rome, Italy Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders. While treating cognitive deficit symptoms in neuropsychiatric or neurodegenerative disorders using CEs might have significant benefits for patients, the increasing recreational use of these substances by healthy individuals raises many clinical, medico-legal, and ethical issues. Moreover, it has become very challenging for clinicians to Edited by: keep up-to-date with CEs currently available as comprehensive official lists do not exist. Simona Pichini, Methods: Using a web crawler (NPSfinder®), the present study aimed at assessing National Institute of Health (ISS), Italy Reviewed by: psychonaut fora/platforms to better understand the online situation regarding CEs.
    [Show full text]
  • Gatekeepers of Addiction?
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW published: 11 November 2016 doi: 10.3389/fncel.2016.00264 Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? Kari A. Johnson and David M. Lovinger * Section on Synaptic Pharmacology, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA Drug abuse and addiction cause widespread social and public health problems, and the neurobiology underlying drug actions and drug use and abuse is an area of intensive research. Drugs of abuse alter synaptic transmission, and these actions contribute to acute intoxication as well as the chronic effects of abused substances. Transmission at most mammalian synapses involves neurotransmitter activation of two receptor subtypes, ligand-gated ion channels that mediate fast synaptic responses and G protein-coupled receptors (GPCRs) that have slower neuromodulatory actions. The GPCRs represent a large proportion of neurotransmitter receptors involved in almost all facets of nervous system function. In addition, these receptors are targets for many pharmacotherapeutic agents. Drugs of abuse directly or indirectly affect neuromodulation mediated by GPCRs, with important consequences for intoxication, drug taking and responses to prolonged drug exposure, withdrawal and addiction. Among the GPCRs are several subtypes involved in presynaptic inhibition, most of which are coupled to the Gi/o class of G protein. There is increasing evidence that these presynaptic Gi/o-coupled GPCRs have important roles in the actions of drugs Edited by: of abuse, as well as behaviors related to these drugs. This topic will be reviewed, Hansen Wang, with particular emphasis on receptors for three neurotransmitters, Dopamine (DA; D1- University of Toronto, Canada and D2-like receptors), Endocannabinoids (eCBs; CB1 receptors) and glutamate (group Reviewed by: Karen K.
    [Show full text]
  • Wake-Promoting Agents Beyond Modafinil
    HIGH POTENCY EUGEROICS— WAKE-PROMOTING AGENTS BEYOND MODAFINIL A Senior Project presented to the Faculty of the Biomedical and General Engineering Department California Polytechnic State University, San Luis Obispo In Partial Fulfillment of the Requirements for the Degree Bachelor of Science in General Engineering by Joseph Yoham April 2015 Modafinil (Provigil) belongs to a new pharmaceutical class known as eugeroics- translating to ‘good arousal’ agents. A distinct structure from classical psychostimulants, modafinil’s unique pharmacological property demonstrates wake-promoting and neuroprotective effects. This literature review presents a hypothesized mechanism of action, consolidates research of modafinil analogues and hybridizes a novel compound in search of a next generation molecule. O O S NH2 (±)-1 modafinil 2-[(diphenylmethyl)sulfinyl]acetamide S-(+)-modafinil R-(-)-modafinil Modafinil (±)-1 contains an asymmetric sulfoxide moiety, where modest enantioselectivity is observed between R-(-)- and S-(+)-modafinil. Investigations into the pharmacokinetic profile of armodafinil confirmed enantioselectivity at DAT for the R- and S-enantiomers was three-fold (Cao et al. 2011) and increased metabolic stability, eliminated three-times more slowly than the S-enantiomer (Robertson et al. 2003). Cephalon Inc. has marketed the racemic sulfoxide, Provigil, since approval in 1998 for 2 narcolepsy. Expansion of its labeling from the initial indications, in 2004 modafinil was approved for treatment of excessive daytime sleepiness (EDS), obstructive sleep apnea/hypopnea syndrome (OSAHS) and shift-work sleep disorder (SWSD). With significance of these prescribing indications rapidly being eroded, the enantiopure R-(-)- isomer, armodafinil (Nuvigil), was approved in 2007 for the same indications. There is now consistent evidence that modafinil can improve prefrontal-dependent cognitive functions of healthy individuals in processes requiring cognitive control.
    [Show full text]
  • Фармакология Pharmacology
    МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ БЕЛАРУСЬ БЕЛОРУССКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ КАФЕДРА ФАРМАКОЛОГИИ ФАРМАКОЛОГИЯ PHARMACOLOGY Практикум для специальности «Лечебное дело» 5-е издание, переработанное Минск БГМУ 2020 2 УДК 615(076.5)(075.8)-054.6 ББК 52.81я73 Ф24 Рекомендовано Научно-методическим советом университета в качестве практикума 29.05.2020 г., протокол № 9 А в т о р ы: проф. Н. А. Бизунок, проф. Б. В. Дубовик, доц. Б. А. Волынец, доц. А. В. Волчек Р е ц е н з е н т ы: д-р мед. наук, проф. А. В. Хапалюк; д-р. мед. наук, проф. А. И. Волотовский Фармакология = Pharmacology : практикум для специальности «Лечебное дело» / Ф24 Н. А. Бизунок [и др.]. – 5-е изд., перераб. – Минск : БГМУ, 2020. – 156 с. ISBN 978-985-21-0643-6. Содержит методические рекомендации для подготовки к лабораторным занятиям по фармакологии и задания для самостоятельной работы студентов, обучающихся по специальности 1-79 01 01 «Лечебное дело». Первое издание вышло в 2016 году. Предназначен для студентов 3-го курса медицинского факультета иностранных учащихся, изучающих фармакологию на английском языке. УДК 615(076.5)(075.8)-054.6 ББК 52.81я73 ISBN 978-985-21-0643-6 © УО «Белорусский государственный медицинский университет», 2020 3 CONTENTS INTRODUCTION ............................................................................................................................................................. 4 GENERAL PRESCRIPTION ...........................................................................................................................................
    [Show full text]
  • List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify
    List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify, abnormal basal ganglia function, abuse of medicines, Aceperone, Acepromazine, Aceprometazine, Acetildenafil, Aceto phenazine, Acetoxy Dipt, Acetyl morphone, Acetyl propionyl morphine, Acetyl psilocin, Activation syndrome, acute anxiety, acute hypertension, acute panic attacks, Adderall, Addictions to drugs, Addictions to medicines, Addictions to substances, Adrenorphin, Adverse effects of psychoactive drugs, adverse reactions to medicines, aggression, aggressive, aggressiveness, agitated depression, Agitation and restlessness, Aildenafil, Akuammine, alcohol abuse, alcohol addiction, alcohol withdrawl, alcohol-related brain damage, alcohol- related liver damage, alcohol mix with medicines for adverse reaction, Alcoholism, Alfetamine, Alimemazine, Alizapride, Alkyl nitrites, allergic breathing reactions to meds, choking to anaphallectic shock, & death; allergic skin reactions to meds, rash, itchyness, hives, welts, etc, Alletorphine, Almorexant, Alnespirone, Alpha Ethyltryptamine, Alpha Neoendorphin, alterations in brain hormones, alterations in mental status, altered consciousness, altered mind, Altoqualine, Alvimopan, Ambien, Amidephrine, Amidorphin, Amiflamine, Amisulpride, Amphetamines, Amyl nitrite, Anafranil, Analeptic, Anastrozole, Anazocine, Anilopam, Antabuse, anti anxiety meds, anti dopaminergic activity, anti seizure meds, Anti convulsants, Anti depressants, Anti emetics, Anti histamines, anti manic meds, anti parkinsonics, Anti psychotics, Anxiety disorders,
    [Show full text]
  • Pill Testing at Music Festivals- Reaching Parts That Other
    Dr Graham Associate Professor Gulbransen David Caldicott General Practitioner Emergency Physician Kingsland Family Health Centre Calvary Hospital Auckland Clinical Lead Australian Drug Observatory 14:00 - 14:55 WS #44: Novel Psychotropic Substances 15:05 - 16:00 WS #56: Novel Psychotropic Substances (Repeated) ‘What Every Clinician Needs to Know About Novel Psychoactive Substances’ Assoc. Prof. David Caldicott B.Sc.(Hons), MBBS(Lond), FRCEM, Dip.Med.Tox Emergency Consultant, Calvary Hospital, Canberra, Australia. Clinical Lead, Australian Drug Observatory, ANU, Canberra, Australia ‘Ajax and Cassandra’, 1886 Solomon J. Solomon, Art Gallery of Ballarat Hail, Hydra… Jason & The Argonauts (1963) Were they ever really ‘novel’...? • Not so much... • Some are tweaks to known compounds • Some are culls from the pharmaceutical research chemistry literature • Dr John Huffman, Clemson University • Dr David Nichols • Dr Alexa Makriyannis, North Eastern University “We had no idea that anybody would be stupid enough to use [them]” Many are less ‘novel’ than they used to be… Club Health, Sydney, 2005… There are now a lot of them out there… There are now a lot of them out there… Not just hurting people… …they’re killing people Drug Induced Deaths Multiple attempts at classification… • Structures • Receptors • Mechanism of action Drugs Wheel- (Mark Adley) Multiple attempts at classifications… Depressants Stimulants Hallucinogens Inebriant Euphoriant Psychedelic Sedative Eugeroic Dissociative Analgesic Entactogen Deliriant Psycho-chemical classification: 3 classes & 9 families (Measham & Newcombe 2015) They emerge really quickly… • “The drug revolution that no one can stop” https://medium.com/matter/19f753fb15e0 • Commissioned the manufacture of 6-CH3 phenmetrazine • Ordered 22nd August, 2013 • Delivered 18th September, 2013 ‘Concierge Drug Design’ They emerge really quickly… Motivations for consumption are the same- and different.
    [Show full text]
  • Drug/Substance Trade Name(S)
    A B C D E F G H I J K 1 Drug/Substance Trade Name(s) Drug Class Existing Penalty Class Special Notation T1:Doping/Endangerment Level T2: Mismanagement Level Comments Methylenedioxypyrovalerone is a stimulant of the cathinone class which acts as a 3,4-methylenedioxypyprovaleroneMDPV, “bath salts” norepinephrine-dopamine reuptake inhibitor. It was first developed in the 1960s by a team at 1 A Yes A A 2 Boehringer Ingelheim. No 3 Alfentanil Alfenta Narcotic used to control pain and keep patients asleep during surgery. 1 A Yes A No A Aminoxafen, Aminorex is a weight loss stimulant drug. It was withdrawn from the market after it was found Aminorex Aminoxaphen, Apiquel, to cause pulmonary hypertension. 1 A Yes A A 4 McN-742, Menocil No Amphetamine is a potent central nervous system stimulant that is used in the treatment of Amphetamine Speed, Upper 1 A Yes A A 5 attention deficit hyperactivity disorder, narcolepsy, and obesity. No Anileridine is a synthetic analgesic drug and is a member of the piperidine class of analgesic Anileridine Leritine 1 A Yes A A 6 agents developed by Merck & Co. in the 1950s. No Dopamine promoter used to treat loss of muscle movement control caused by Parkinson's Apomorphine Apokyn, Ixense 1 A Yes A A 7 disease. No Recreational drug with euphoriant and stimulant properties. The effects produced by BZP are comparable to those produced by amphetamine. It is often claimed that BZP was originally Benzylpiperazine BZP 1 A Yes A A synthesized as a potential antihelminthic (anti-parasitic) agent for use in farm animals.
    [Show full text]
  • Cognitive Enhancement Treating Or Cheating?
    Author's Accepted Manuscript Cognitive enhancement: Treating or cheating? Leslie M. Whetstine PhD PII: S1071-9091(15)00039-X www.elsevier.com/locate/enganabound DOI: http://dx.doi.org/10.1016/j.spen.2015.05.003 Reference: YSPEN547 To appear in: Semin Pediatr Neurol Cite this article as: Leslie M. Whetstine PhD, Cognitive enhancement: Treating or cheating?, Semin Pediatr Neurol , http://dx.doi.org/10.1016/j.spen.2015.05.003 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Author: Leslie M Whetstine, PhD Associate Professor, Philosophy Walsh University 2020 East Maple St North Canton, OH 44720 [email protected] Title: Cognitive Enhancement: Treating or Cheating? Abstract: In this article I provide an overview of the moral and medical questions surrounding the use of cognitive enhancers. The discussion will be framed in light of four key considerations (1) is there a difference between therapy and enhancement? (2) How safe are these interventions? (3) Is the use of nootropics cheating? (4) Will enhancers create a further divide of social inequality where only the very wealthy will have access to them? Keywords: Cognitive enhancement, nootropics, ethics, cheating 1 Case: Peter's mother brought him to his pediatrician to request she prescribe Ritalin.
    [Show full text]
  • Nootropics Use in the Workplace: Psychiatric and Ethical Aftermath Towards the New Frontier of Bioengineering
    European Review for Medical and Pharmacological Sciences 2020; 24: 2129-2139 Nootropics use in the workplace: psychiatric and ethical aftermath towards the new frontier of bioengineering S. ZAAMI1, R. RINALDI1, G. BERSANI2, A. DEL RIO1, C. CIALLELLA1, E. MARINELLI1 1Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Departmental Section of Legal Medicine, “Sapienza” University of Rome, Rome, Italy 2Department of Medico-Surgical Sciences and Biotechnologies, “Sapienza” University of Rome, Rome, Italy Abstract. – OBJECTIVE: The authors have Key Words: sought to expound upon and shed a light on the Nootropics, Human Enhancement, Productivity, rise of nootropics, which have gradually taken Workplace, Bioengineering, Ethics. on a more and more relevant role in workplaces and academic settings. MATERIALS AND METHODS: Multidisciplinary Introduction databases have been delved into by entering the following keys: “nootropics”, “cognitive enhance- ment”, “workplace”, “productivity”, “ethics”, “bio- The use of therapeutic drugs for non-medical engineering”. In addition, a broad-ranging search reasons as cognitive enhancers has been spreading has been undertaken on institutional websites in and its risks seem to have become at least in part order to identify relevant analysis and recommen- acceptable among students and certain groups of dations issued by international institutions and workers. Considering the ever more competitive agencies. Papers and reports have been inde- pendently pored over by each author. This search nature of modern societies, which reverberates on strategy has led to the identification of 988 sourc- workplaces as well, enhancers are reasonably ex- es but only 64 were considered appropriate for the pected to spread even more over time; nonetheless, purposes of the paper after being selected by at long-term consequences arising from their becom- least 3 of the authors, independently.
    [Show full text]
  • 'Smart Drug' Modafinil Does Enhance Cognition
    Media Release: European College of Neuropsychopharmacology (ECNP) “For the science and treatment of disorders of the brain” Systematic review shows ‘smart drug’ modafinil does enhance cognition Embargo until: 00.05 British Summer Time, Thursday 20th August 2015 The drug modafinil was developed to treat narcolepsy (excessive sleeping), but it is widely used off- licence as a ‘smart drug’ to promote cognitive enhancement, where qualities such as alertness and concentration are desired to assist someone with, for example, exam preparation. Past studies on sleep-deprived individuals have shown a strong positive effect of modafinil on these functions, but there has been less attention and scientific consensus on the drug’s overall effectiveness as a cognitive enhancer in people that are not sleep-deprived – presumably the majority of people taking it. Now, a new systematic review, published online in the peer-reviewed journal European Neuropsychopharmacology* shows that modafinil does indeed confer significant cognitive benefits in this group, at least on a particular subset of tasks. Dr Ruairidh Battleday and Dr Anna-Katharine Brem from the University of Oxford and Harvard Medical School evaluated all research papers on cognitive enhancement with modafinil from January 1990 to December 2014. They found 24 studies dealing with different benefits associated with taking modafinil, including planning and decision making, flexibility, learning and memory, and creativity. Unsurprisingly, they found that the performance-enhancing capacity of modafinil varied according to the task. What emerged was that the longer and more complex the task tested, the more consistently modafinil conferred cognitive benefits. Modafinil made no difference to working memory, or flexibility of thought, but did improve decision- making and planning.
    [Show full text]